关于脂质纳米颗粒如何与基于膜的生物屏障相互作用的机制和战略见解
Yun Zhao1, Chong Liu2, Xinyue Zhang2
1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology (NCNST), Beijing 100190, China.
ACS nano
|March 12, 2026
概括
脂质纳米粒子 (LNP) 面临着影响核酸输送的生物障碍. 了解跨各种管理途径和细胞屏障的LNP-膜相互作用是开发先进LNP治疗方法的关键.
科学领域:
- 纳米医学和药物输送
- 生物物理学的生物物理.
- 生物化学 生物化学
背景情况:
- 脂质纳米颗粒 (LNP) 对于核酸输送至关重要,但在体内面临生物障碍的重大挑战.
- 这些障碍,包括细胞外矩阵,粘膜层和细胞膜,对LNP运输,细胞进入和货物释放施加物理化学约束.
研究的目的:
- 为了解LNP-膜相互作用提供一个机制框架.
- 为了整合膜生物物理学,脂质化学,界面力和蛋白质冠状形成.
- 引导下一代LNP交付系统的合理开发.
主要方法:
- 在多个层次层次上对LNP与生物障碍的相互作用进行审查.
- 膜生物物理学,脂质化学和纳米生物界面原理的整合.
- 在各种管理路径和细胞类型中分析LNP行为.
主要成果:
- 膜屏障决定了LNP运输,细胞进入和货物释放.
- 给药途径,局部结构和蛋白质冠状病毒影响生物分布和向.
- 细胞膜特性和器官细胞过程调节细胞内贩运和mRNA释放.
- 通过限制性障碍和二次传递机制进行LNP转细胞化的证据.
结论:
- 对LNP-膜相互作用的机制性理解对于优化治疗性能至关重要.
- 对LNP的合理设计需要将分子性质与生物物理和界面原则相结合.
- 未来的LNP开发可以通过对障碍透和细胞内传递的全面视角来指导.
相关概念视频
Bioavailability Enhancement: Drug Permeability Enhancement
290
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
290
Asymmetric Lipid Bilayer
10.7K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
10.7K


